3692:HKG
Hansoh Pharmaceutical Group Company Ltd
HK$31,74
arrow_upward
+1,15%(+0,36) 1D
16 ຕ.ລ., 16 ໂມງ 8 ນາທີ 14 ວິນາທີ GMT+8 · HKD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 3692...
Open
HK$31,72
High
HK$32,44
Low
HK$31,52
Mkt. cap
192,48 ຕື້
Avg. vol.
8,58 ລ້ານ
Volume
10,50 ລ້ານ
Dividend
1,53%
Quarterly dividend
HK$0,12
Ex-dividend date
22 ກ.ຍ. 2026
P/E ratio
24,51
52-wk high
HK$44,22
52-wk low
HK$28,06
EPS
HK$1,30
No. of employees
10 ພັນ
Open
HK$31,72
High
HK$32,44
Low
HK$31,52
Mkt. cap
192,48 ຕື້
Avg. vol.
8,58 ລ້ານ
Volume
10,50 ລ້ານ
Dividend
1,53%
Quarterly dividend
HK$0,12
Ex-dividend date
22 ກ.ຍ. 2026
P/E ratio
24,51
52-wk high
HK$44,22
52-wk low
HK$28,06
EPS
HK$1,30
No. of employees
10 ພັນ
News stories
From web sources and news partners
ad-hoc-news.de
·
2 ຊົ່ວໂມງກ່ອນ
Hansoh Pharma stock gets HKD 47.82 consensus target
Simply Wall Street
·
2 ຊົ່ວໂມງກ່ອນ
Could EMA Review Alter The Investment Case For Hansoh Pharma Stock (SEHK:3692)?
Profile
Hansoh Pharmaceutical Group Company Limited is a pharmaceutical company that manufactures and sells various types of medicine in mainland China. It was founded in 1995 in Lianyungang, Jiangsu Province, China, by Zhong Huijuan, who is the company's chair. Zhong and her family own 66% of the company. It is the largest psychotropic drug producer in China.
Hansoh Pharmaceutical had an initial public offering on the main board of the Hong Kong Stock Exchange on 14 June 2019.
In August 2022, it was announced that the company's stock would be added to the Hang Seng Index. Wikipedia
About Hansoh Pharmaceutical Group Company Ltd